83_FR_38301
Page Range | 38151-38153 | |
FR Document | 2018-16618 |
[Federal Register Volume 83, Number 150 (Friday, August 3, 2018)] [Notices] [Pages 38151-38153] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-16618] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2018-N-0405] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Device Recall Authority AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the [[Page 38152]] Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by September 4, 2018. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, Fax: 202-395-7285, or emailed to [email protected]. All comments should be identified with the OMB control number 0910-0432. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, [email protected]. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Medical Device Recall Authority OMB Control Number 0910-0432--Extension This collection of information implements section 518(e) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360h(e)) and part 810 (21 CFR part 810), mandatory medical device recall authority provisions. Section 518(e) of the FD&C Act provides FDA with the authority to issue an order requiring an appropriate person, including manufacturers, importers, distributors, and retailers of a device, if FDA finds that there is reasonable probability that the device intended for human use would cause serious adverse health consequences or death, to: (1) Immediately cease distribution of such device and (2) immediately notify health professionals and device-user facilities of the order and to instruct such professionals and facilities to cease use of such device. FDA will then provide the person named in the cease distribution and notification order with the opportunity for an informal hearing on whether the order should be amended to require a mandatory recall of the device. If, after providing the opportunity for an informal hearing, FDA determines that such an order is necessary, the Agency may amend the order to require a mandatory recall. FDA issued part 810 to implement the provisions of section 518 of the FD&C Act. The information collected under the mandatory recall authority provisions will be used by FDA to implement mandatory recalls. In the Federal Register of February 22, 2018 (83 FR 7740), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received. FDA estimates the burden of this collection of information as follows: Table 1--Estimated Annual Reporting Burden 1 ---------------------------------------------------------------------------------------------------------------- Number of Collection activity/21 CFR Number of responses per Total annual Average burden Total hours section respondents respondent responses per response ---------------------------------------------------------------------------------------------------------------- Collections Specified in the 2 1 2 8 16 Order--810.10(d)............... Request for Regulatory Hearing-- 1 1 1 8 8 810.11(a)...................... Written Request for Review-- 1 1 1 8 8 810.12(a)-(b).................. Mandatory Recall Strategy-- 2 1 2 16 32 810.14......................... Periodic Status Reports-- 2 12 24 40 960 810.16(a)-(b).................. Termination Request--810.17(a).. 2 1 2 8 16 ------------------------------------------------------------------------------- Total Hours................. .............. .............. .............. .............. 1,040 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. Table 2--Estimated Annual Recordkeeping Burden 1 -------------------------------------------------------------------------------------------------------------------------------------------------------- Number of Average burden Collection activity/21 CFR section Number of records per Total annual per Total hours recordkeepers recordkeeper records recordkeeping -------------------------------------------------------------------------------------------------------------------------------------------------------- Documentation of Notifications to Recipients--810.15(b)............ 2 1 2 8 16 -------------------------------------------------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. Table 3--Estimated Annual Third-Party Disclosure Burden 1 ---------------------------------------------------------------------------------------------------------------- Number of Collection activity/21 CFR Number of disclosures Total annual Average burden Total hours section respondents per respondent disclosures per disclosure ---------------------------------------------------------------------------------------------------------------- Notification to Recipients-- 2 1 2 12 24 810.15(a)-(c).................. Notification to Recipients; 2 1 2 4 8 Follow-up--810.15(d)........... Notification of Consignees by 10 1 10 1 10 Recipients--810.15(e).......... ------------------------------------------------------------------------------- Total....................... .............. .............. .............. .............. 42 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. [[Page 38153]] The burden estimate has not changed for information collection related to section 518(e) of the FD&C Act and part 810 since the last OMB approval. Dated: July 24, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018-16618 Filed 8-2-18; 8:45 am] BILLING CODE 4164-01-P
Category | Regulatory Information | |
Collection | Federal Register | |
sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
Publisher | Office of the Federal Register, National Archives and Records Administration | |
Section | Notices | |
Action | Notice. | |
Dates | Fax written comments on the collection of information by September 4, 2018. | |
Contact | Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, [email protected] | |
FR Citation | 83 FR 38151 |